Any one know about this.

Found this on the web:

The second speaker was Dr. Ronald Swerdloff, UCLA School of Medicine, Torrance, California, who presented "Pharmacodynamics of Androgen Replacement Therapy in Middle-aged and Older Men". He noted that availability of SARMs (selective androgen receptor modulators) to treat testosterone deficient men would be at least 10 years away and that what has occurred in TRT over the past years has been development of new testosterone delivery systems.

Source: http://andrology.org/Members/janos/fertility/2000062101/view

The above article was published in 2000 so I'd expect this to be ready for the market in five or so years.

That SARMs on that website are in phase three studies for high risk prostate cancer groups and phase 1 in another cancer trial. Looks like they have a long way to go before it's available on the market. Should be interesting to see what those, and future, studies show.
 
Back
Top